Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-19-002988

Director acquired 251,835 shares (other)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-16 Other acquisition : show line 1 in the form +251,835 $1.32 $332,397 33,980,826 D
2019-04-16 Other acquisition : show line 2 in the form +0 33,980,826 I
Loading xslF345X03/ownership.xml…